P15208
Gene name |
Insr |
Protein name |
Insulin receptor |
Names |
IR , EC 2.7.10.1 , CD antigen CD220 [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:16337 |
EC number |
2.7.10.1: Protein-tyrosine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
1013-1288 (FnIII-2 domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
1166-1191 (Activation loop from InterPro)
Target domain |
1013-1288 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
1166-1191 (Activation loop from InterPro)
Target domain |
1013-1288 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Craddock BP et al. (2007) "Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region", FEBS letters, 581, 3235-40
- Uchikawa E et al. (2019) "Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex", eLife, 8,
- Nielsen J et al. (2022) "Structural Investigations of Full-Length Insulin Receptor Dynamics and Signalling", Journal of molecular biology, 434, 167458
- Chen YS et al. (2021) "Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation", Proceedings of the National Academy of Sciences of the United States of America, 118,
- Huang X et al. (2009) "Structural insights into the inhibited states of the Mer receptor tyrosine kinase", Journal of structural biology, 165, 88-96
- Hubbard SR (2004) "Juxtamembrane autoinhibition in receptor tyrosine kinases", Nature reviews. Molecular cell biology, 5, 464-71
- Hubbard SR et al. (1994) "Crystal structure of the tyrosine kinase domain of the human insulin receptor", Nature, 372, 746-54
Autoinhibited structure

Activated structure

17 structures for P15208
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
1LK2 | X-ray | 135 A | P | 423-430 | PDB |
7SL1 | EM | 340 A | A/B | 1-1372 | PDB |
7SL2 | EM | 360 A | A/B | 1-1372 | PDB |
7SL3 | EM | 340 A | A/B | 1-1372 | PDB |
7SL4 | EM | 500 A | A/B | 1-1372 | PDB |
7SL6 | EM | 370 A | A/B | 1-1372 | PDB |
7SL7 | EM | 310 A | A/B | 1-1372 | PDB |
7STH | EM | 350 A | A/B | 1-1372 | PDB |
7STI | EM | 490 A | A/B | 1-1372 | PDB |
7STJ | EM | 440 A | A/B | 1-1372 | PDB |
7STK | EM | 400 A | A/B | 1-1372 | PDB |
8DTL | EM | 540 A | A/B | 28-1372 | PDB |
8DTM | EM | 350 A | A/B | 28-1372 | PDB |
8EYX | EM | 450 A | A/B | 28-1372 | PDB |
8EYY | EM | 490 A | A/B | 28-1372 | PDB |
8EZ0 | EM | 370 A | A/B | 28-1372 | PDB |
AF-P15208-F1 | Predicted | AlphaFoldDB |
71 variants for P15208
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3388960161 | 23 | V>M | No | EVA | |
rs3388936833 | 49 | E>V | No | EVA | |
rs3388948380 | 83 | M>T | No | EVA | |
rs3388963815 | 85 | T>A | No | EVA | |
rs3388970263 | 93 | V>I | No | EVA | |
rs3388971154 | 95 | G>S | No | EVA | |
rs864272203 | 223 | C>S | No | EVA | |
rs3388919284 | 247 | D>Y | No | EVA | |
rs3388960157 | 254 | A>T | No | EVA | |
rs3388967641 | 263 | Q>E | No | EVA | |
rs3388963796 | 264 | C>* | No | EVA | |
rs3388953319 | 286 | C>* | No | EVA | |
rs3388960154 | 303 | Q>H | No | EVA | |
rs3388960151 | 313 | P>L | No | EVA | |
rs3388948299 | 334 | P>S | No | EVA | |
rs3388963782 | 347 | T>I | No | EVA | |
rs3413101001 | 369 | I>V | No | EVA | |
rs3388959659 | 376 | N>S | No | EVA | |
rs3388936826 | 406 | L>V | No | EVA | |
rs3388943398 | 425 | Y>H | No | EVA | |
rs51045081 | 445 | N>S | No | EVA | |
rs3398687439 | 466 | I>F | No | EVA | |
rs3388967710 | 473 | S>T | No | EVA | |
rs3388963848 | 487 | K>R | No | EVA | |
rs3388970266 | 490 | G>W | No | EVA | |
rs3388970251 | 566 | R>K | No | EVA | |
rs3388967712 | 573 | Q>H | No | EVA | |
rs3388964263 | 582 | M>L | No | EVA | |
rs3388953345 | 608 | Y>* | No | EVA | |
rs3388966698 | 643 | K>T | No | EVA | |
rs3388936879 | 660 | Y>* | No | EVA | |
rs3388963795 | 661 | W>S | No | EVA | |
rs3388953349 | 683 | P>L | No | EVA | |
rs3388919292 | 692 | E>D | No | EVA | |
rs3388943451 | 695 | D>E | No | EVA | |
rs237250166 | 750 | K>N | No | EVA | |
rs48498754 | 771 | P>S | No | EVA | |
rs49713587 | 773 | V>I | No | EVA | |
rs3388967998 | 801 | G>D | No | EVA | |
rs3388963816 | 804 | H>Y | No | EVA | |
rs3398687460 | 809 | R>S | No | EVA | |
rs3388953327 | 848 | T>I | No | EVA | |
rs3388943284 | 874 | Y>C | No | EVA | |
rs3388919338 | 876 | V>E | No | EVA | |
rs3388971163 | 907 | S>Y | No | EVA | |
rs3388959668 | 931 | Y>* | No | EVA | |
rs3388963805 | 932 | F>I | No | EVA | |
rs3388970272 | 1008 | V>A | No | EVA | |
rs46766839 | 1015 | L>F | No | EVA | |
rs3388936884 | 1021 | Q>L | No | EVA | |
rs3388936884 | 1021 | Q>R | No | EVA | |
rs3388943409 | 1073 | C>F | No | EVA | |
rs3398777057 | 1075 | H>P | No | EVA | |
rs3388967961 | 1084 | S>T | No | EVA | |
rs3388960095 | 1106 | R>H | No | EVA | |
rs3388960095 | 1106 | R>P | No | EVA | |
rs3388966750 | 1118 | R>H | No | EVA | |
rs3388919287 | 1126 | M>L | No | EVA | |
rs3388959629 | 1128 | Q>K | No | EVA | |
rs3388963829 | 1163 | V>I | No | EVA | |
rs3388919332 | 1170 | M>L | No | EVA | |
rs3388963789 | 1171 | T>I | No | EVA | |
rs3388969003 | 1177 | T>A | No | EVA | |
rs3388965441 | 1179 | Y>* | No | EVA | |
rs3388960124 | 1182 | K>R | No | EVA | |
rs3411762441 | 1217 | W>R | No | EVA | |
rs3388967668 | 1288 | F>I | No | EVA | |
rs3388948310 | 1329 | E>* | No | EVA | |
rs3388959670 | 1332 | G>D | No | EVA | |
rs3388959620 | 1334 | E>* | No | EVA | |
rs3388919267 | 1360 | N>K | No | EVA |
No associated diseases with P15208
14 regional properties for P15208
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Receptor L-domain | 52 - 163 | IPR000494-1 |
domain | Receptor L-domain | 359 - 470 | IPR000494-2 |
domain | Protein kinase domain | 1013 - 1288 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 1013 - 1279 | IPR001245 |
conserved_site | Tyrosine-protein kinase, receptor class II, conserved site | 1173 - 1181 | IPR002011 |
domain | Fibronectin type III | 496 - 602 | IPR003961-1 |
domain | Fibronectin type III | 624 - 821 | IPR003961-2 |
domain | Fibronectin type III | 841 - 937 | IPR003961-3 |
domain | Furin-like cysteine-rich domain | 179 - 340 | IPR006211 |
repeat | Furin-like repeat | 231 - 281 | IPR006212 |
active_site | Tyrosine-protein kinase, active site | 1145 - 1157 | IPR008266 |
binding_site | Protein kinase, ATP binding site | 1019 - 1047 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 1013 - 1280 | IPR020635 |
domain | Insulin receptor, trans-membrane domain | 930 - 977 | IPR040969 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.1 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
17 GO annotations of cellular component
Name | Definition |
---|---|
axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
caveola | A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. |
dendrite membrane | The portion of the plasma membrane surrounding a dendrite. |
endosome | A vacuole to which materials ingested by endocytosis are delivered. |
external side of plasma membrane | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
insulin receptor complex | A disulfide-bonded, heterotetrameric receptor complex. The alpha chains are entirely extracellular, while each beta chain has one transmembrane domain. The ligand binds to the alpha subunit extracellular domain and the kinase is associated with the beta subunit intracellular domain. |
late endosome | A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center. |
lysosome | A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. |
neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
neuronal cell body membrane | The plasma membrane of a neuron cell body - excludes the plasma membrane of cell projections such as axons and dendrites. |
nuclear envelope | The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space). |
nuclear lumen | The volume enclosed by the nuclear inner membrane. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
receptor complex | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
recycling endosome membrane | The lipid bilayer surrounding a recycling endosome. |
yolk | The cytoplasmic part that serves as a nutrient reserve or energy source for the developing embryo. |
20 GO annotations of molecular function
Name | Definition |
---|---|
3-phosphoinositide-dependent protein kinase binding | Binding to a 3-phosphoinositide-dependent protein kinase. |
amyloid-beta binding | Binding to an amyloid-beta peptide/protein. |
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
cargo receptor activity | Binding specifically to a substance (cargo) to deliver it to a transport vesicle. Cargo receptors span a membrane (either the plasma membrane or a vesicle membrane), binding simultaneously to cargo molecules and coat adaptors, to efficiently recruit soluble proteins to nascent vesicles. |
GTP binding | Binding to GTP, guanosine triphosphate. |
insulin binding | Binding to insulin, a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
insulin receptor activity | Combining with insulin receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
insulin receptor substrate binding | Binding to an insulin receptor substrate (IRS) protein, an adaptor protein that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex. |
insulin-like growth factor I binding | Binding to insulin-like growth factor I. |
insulin-like growth factor II binding | Binding to insulin-like growth factor II. |
insulin-like growth factor receptor binding | Binding to an insulin-like growth factor receptor. |
lipoic acid binding | Binding to lipoic acid, 1,2-dithiolane-3-pentanoic acid. |
phosphatidylinositol 3-kinase binding | Binding to a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring. |
protein domain specific binding | Binding to a specific domain of a protein. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
protein phosphatase binding | Binding to a protein phosphatase. |
protein tyrosine kinase activity | Catalysis of the reaction |
protein-containing complex binding | Binding to a macromolecular complex. |
PTB domain binding | Binding to a phosphotyrosine-binding (PTB) Binding to a phosphotyrosine-bindin domain. |
44 GO annotations of biological process
Name | Definition |
---|---|
adrenal gland development | The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells. |
amyloid-beta clearance | The process in which amyloid-beta is removed from extracellular brain regions by mechanisms involving cell surface receptors. |
animal organ morphogenesis | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
cellular response to growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. |
dendritic spine maintenance | The organization process that preserves a dendritic spine in a stable functional or structural state. A dendritic spine is a specialized protrusion from a neuronal dendrite and is involved in synaptic transmission. |
epidermis development | The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species. |
exocrine pancreas development | The process whose specific outcome is the progression of the exocrine pancreas over time, from its formation to the mature structure. The exocrine pancreas produces and store zymogens of digestive enzymes, such as chymotrypsinogen and trypsinogen in the acinar cells. |
G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
glucose homeostasis | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
heart morphogenesis | The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
insulin receptor signaling pathway | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
male gonad development | The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. |
male sex determination | The specification of male sex of an individual organism. |
negative regulation of feeding behavior | Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior. |
negative regulation of gene expression | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
negative regulation of protein phosphorylation | Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein. |
neuron projection maintenance | The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of developmental growth | Any process that activates, maintains or increases the rate of developmental growth. |
positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of glucose import | Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
positive regulation of glycogen biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
positive regulation of glycolytic process | Any process that activates or increases the frequency, rate or extent of glycolysis. |
positive regulation of glycoprotein biosynthetic process | Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of a glycoprotein, a protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. |
positive regulation of MAPK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
positive regulation of meiotic cell cycle | Any process that activates or increases the frequency, rate or extent of progression through the meiotic cell cycle. |
positive regulation of mitotic nuclear division | Any process that activates or increases the frequency, rate or extent of mitosis. |
positive regulation of nitric oxide biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
positive regulation of phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of protein-containing complex disassembly | Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components. |
positive regulation of receptor internalization | Any process that activates or increases the frequency, rate or extent of receptor internalization. |
positive regulation of respiratory burst | Any process that increases the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals. |
protein autophosphorylation | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
receptor internalization | A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. |
receptor-mediated endocytosis | An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles. |
regulation of embryonic development | Any process that modulates the frequency, rate or extent of embryonic development. |
regulation of female gonad development | Any process that modulates the frequency, rate or extent of female gonad development. |
regulation of hydrogen peroxide metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide. |
response to nutrient levels | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
response to tumor necrosis factor | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
symbiont entry into host cell | The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm. |
70 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q05688 | IGF1R | Insulin-like growth factor 1 receptor | Bos taurus (Bovine) | SS |
P09208 | InR | Insulin-like receptor | Drosophila melanogaster (Fruit fly) | SS |
P08069 | IGF1R | Insulin-like growth factor 1 receptor | Homo sapiens (Human) | EV |
P14616 | INSRR | Insulin receptor-related protein | Homo sapiens (Human) | SS |
P06213 | INSR | Insulin receptor | Homo sapiens (Human) | EV |
Q9WTL4 | Insrr | Insulin receptor-related protein | Mus musculus (Mouse) | SS |
Q00993 | Axl | Tyrosine-protein kinase receptor UFO | Mus musculus (Mouse) | PR |
Q03145 | Epha2 | Ephrin type-A receptor 2 | Mus musculus (Mouse) | PR |
Q60805 | Mertk | Tyrosine-protein kinase Mer | Mus musculus (Mouse) | SS |
Q9Z138 | Ror2 | Tyrosine-protein kinase transmembrane receptor ROR2 | Mus musculus (Mouse) | SS |
Q3UFB7 | Ntrk1 | High affinity nerve growth factor receptor | Mus musculus (Mouse) | SS |
Q9Z139 | Ror1 | Inactive tyrosine-protein kinase transmembrane receptor ROR1 | Mus musculus (Mouse) | PR |
Q60629 | Epha5 | Ephrin type-A receptor 5 | Mus musculus (Mouse) | SS |
Q60750 | Epha1 | Ephrin type-A receptor 1 | Mus musculus (Mouse) | SS |
P97793 | Alk | ALK tyrosine kinase receptor | Mus musculus (Mouse) | SS |
P54761 | Ephb4 | Ephrin type-B receptor 4 | Mus musculus (Mouse) | PR |
P35546 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Mus musculus (Mouse) | SS |
Q61006 | Musk | Muscle, skeletal receptor tyrosine-protein kinase | Mus musculus (Mouse) | SS |
Q62371 | Ddr2 | Discoidin domain-containing receptor 2 | Mus musculus (Mouse) | SS |
Q03146 | Ddr1 | Epithelial discoidin domain-containing receptor 1 | Mus musculus (Mouse) | SS |
P15209 | Ntrk2 | BDNF/NT-3 growth factors receptor | Mus musculus (Mouse) | SS |
Q6VNS1 | Ntrk3 | NT-3 growth factor receptor | Mus musculus (Mouse) | SS |
P35917 | Flt4 | Vascular endothelial growth factor receptor 3 | Mus musculus (Mouse) | SS |
P35969 | Flt1 | Vascular endothelial growth factor receptor 1 | Mus musculus (Mouse) | SS |
P35918 | Kdr | Vascular endothelial growth factor receptor 2 | Mus musculus (Mouse) | PR |
Q60751 | Igf1r | Insulin-like growth factor 1 receptor | Mus musculus (Mouse) | SS |
P16092 | Fgfr1 | Fibroblast growth factor receptor 1 | Mus musculus (Mouse) | SS |
P21803 | Fgfr2 | Fibroblast growth factor receptor 2 | Mus musculus (Mouse) | SS |
Q03142 | Fgfr4 | Fibroblast growth factor receptor 4 | Mus musculus (Mouse) | PR |
Q62190 | Mst1r | Macrophage-stimulating protein receptor | Mus musculus (Mouse) | SS |
P55144 | Tyro3 | Tyrosine-protein kinase receptor TYRO3 | Mus musculus (Mouse) | SS |
P70424 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Mus musculus (Mouse) | SS |
Q61527 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Mus musculus (Mouse) | SS |
Q61526 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Mus musculus (Mouse) | SS |
Q01279 | Egfr | Epidermal growth factor receptor | Mus musculus (Mouse) | SS |
Q01887 | Ryk | Tyrosine-protein kinase RYK | Mus musculus (Mouse) | PR |
Q02858 | Tek | Angiopoietin-1 receptor | Mus musculus (Mouse) | SS |
Q06806 | Tie1 | Tyrosine-protein kinase receptor Tie-1 | Mus musculus (Mouse) | SS |
P05532 | Kit | Mast/stem cell growth factor receptor Kit | Mus musculus (Mouse) | PR |
P05622 | Pdgfrb | Platelet-derived growth factor receptor beta | Mus musculus (Mouse) | SS |
P09581 | Csf1r | Macrophage colony-stimulating factor 1 receptor | Mus musculus (Mouse) | SS |
P26618 | Pdgfra | Platelet-derived growth factor receptor alpha | Mus musculus (Mouse) | SS |
Q00342 | Flt3 | Receptor-type tyrosine-protein kinase FLT3 | Mus musculus (Mouse) | SS |
P16056 | Met | Hepatocyte growth factor receptor | Mus musculus (Mouse) | PR |
Q61851 | Fgfr3 | Fibroblast growth factor receptor 3 | Mus musculus (Mouse) | PR |
Q64716 | Insrr | Insulin receptor-related protein | Rattus norvegicus (Rat) | SS |
P24062 | Igf1r | Insulin-like growth factor 1 receptor | Rattus norvegicus (Rat) | SS |
P15127 | Insr | Insulin receptor | Rattus norvegicus (Rat) | SS |
Q9SXB5 | At1g11303 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g11303 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9LPZ9 | SD113 | G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 | Arabidopsis thaliana (Mouse-ear cress) | SS |
Q9LMN7 | WAK5 | Wall-associated receptor kinase 5 | Arabidopsis thaliana (Mouse-ear cress) | PR |
O64783 | At1g61370 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O64770 | At1g61490 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 | Arabidopsis thaliana (Mouse-ear cress) | SS |
Q9SYA0 | At1g61500 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 | Arabidopsis thaliana (Mouse-ear cress) | SS |
Q9LW83 | CES101 | G-type lectin S-receptor-like serine/threonine-protein kinase CES101 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9LSV3 | WAKL16 | Putative wall-associated receptor kinase-like 16 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9M342 | WAKL15 | Wall-associated receptor kinase-like 15 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q8VZJ9 | CRCK2 | Calmodulin-binding receptor-like cytoplasmic kinase 2 | Arabidopsis thaliana (Mouse-ear cress) | PR |
O81833 | SD11 | G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 | Arabidopsis thaliana (Mouse-ear cress) | PR |
O64778 | At1g61420 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61420 | Arabidopsis thaliana (Mouse-ear cress) | SS |
Q9SY95 | At1g61550 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O64776 | At1g61440 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61440 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O64780 | At1g61400 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 | Arabidopsis thaliana (Mouse-ear cress) | SS |
Q9SXB4 | At1g11300 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 | Arabidopsis thaliana (Mouse-ear cress) | PR |
O64477 | At2g19130 | G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O64782 | SD129 | G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O64774 | At1g61460 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61460 | Arabidopsis thaliana (Mouse-ear cress) | PR |
O64793 | At1g67520 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q39203 | SD22 | G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O64784 | At1g61360 | G-type lectin S-receptor-like serine/threonine-protein kinase At1g61360 | Arabidopsis thaliana (Mouse-ear cress) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MGFGRGCETT | AVPLLVAVAA | LLVGTAGHLY | PGEVCPGMDI | RNNLTRLHEL | ENCSVIEGHL |
70 | 80 | 90 | 100 | 110 | 120 |
QILLMFKTRP | EDFRDLSFPK | LIMITDYLLL | FRVYGLESLK | DLFPNLTVIR | GSRLFFNYAL |
130 | 140 | 150 | 160 | 170 | 180 |
VIFEMVHLKE | LGLYNLMNIT | RGSVRIEKNN | ELCYLATIDW | SRILDSVEDN | YIVLNKDDNE |
190 | 200 | 210 | 220 | 230 | 240 |
ECGDVCPGTA | KGKTNCPATV | INGQFVERCW | THSHCQKVCP | TICKSHGCTA | EGLCCHKECL |
250 | 260 | 270 | 280 | 290 | 300 |
GNCSEPDDPT | KCVACRNFYL | DGQCVETCPP | PYYHFQDWRC | VNFSFCQDLH | FKCRNSRKPG |
310 | 320 | 330 | 340 | 350 | 360 |
CHQYVIHNNK | CIPECPSGYT | MNSSNLMCTP | CLGPCPKVCQ | ILEGEKTIDS | VTSAQELRGC |
370 | 380 | 390 | 400 | 410 | 420 |
TVINGSLIIN | IRGGNNLAAE | LEANLGLIEE | ISGFLKIRRS | YALVSLSFFR | KLHLIRGETL |
430 | 440 | 450 | 460 | 470 | 480 |
EIGNYSFYAL | DNQNLRQLWD | WSKHNLTITQ | GKLFFHYNPK | LCLSEIHKME | EVSGTKGRQE |
490 | 500 | 510 | 520 | 530 | 540 |
RNDIALKTNG | DQASCENELL | KFSFIRTSFD | KILLRWEPYW | PPDFRDLLGF | MLFYKEAPYQ |
550 | 560 | 570 | 580 | 590 | 600 |
NVTEFDGQDA | CGSNSWTVVD | IDPPQRSNDP | KSQTPSHPGW | LMRGLKPWTQ | YAIFVKTLVT |
610 | 620 | 630 | 640 | 650 | 660 |
FSDERRTYGA | KSDIIYVQTD | ATNPSVPLDP | ISVSNSSSQI | ILKWKPPSDP | NGNITHYLVY |
670 | 680 | 690 | 700 | 710 | 720 |
WERQAEDSEL | FELDYCLKGL | KLPSRTWSPP | FESDDSQKHN | QSEYDDSASE | CCSCPKTDSQ |
730 | 740 | 750 | 760 | 770 | 780 |
ILKELEESSF | RKTFEDYLHN | VVFVPRPSRK | RRSLEEVGNV | TATTLTLPDF | PNVSSTIVPT |
790 | 800 | 810 | 820 | 830 | 840 |
SQEEHRPFEK | VVNKESLVIS | GLRHFTGYRI | ELQACNQDSP | DERCSVAAYV | SARTMPEAKA |
850 | 860 | 870 | 880 | 890 | 900 |
DDIVGPVTHE | IFENNVVHLM | WQEPKEPNGL | IVLYEVSYRR | YGDEELHLCV | SRKHFALERG |
910 | 920 | 930 | 940 | 950 | 960 |
CRLRGLSPGN | YSVRVRATSL | AGNGSWTEPT | YFYVTDYLDV | PSNIAKIIIG | PLIFVFLFSV |
970 | 980 | 990 | 1000 | 1010 | 1020 |
VIGSIYLFLR | KRQPDGPMGP | LYASSNPEYL | SASDVFPSSV | YVPDEWEVPR | EKITLLRELG |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
QGSFGMVYEG | NAKDIIKGEA | ETRVAVKTVN | ESASLRERIE | FLNEASVMKG | FTCHHVVRLL |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
GVVSKGQPTL | VVMELMAHGD | LKSHLRSLRP | DAENNPGRPP | PTLQEMIQMT | AEIADGMAYL |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
NAKKFVHRDL | AARNCMVAHD | FTVKIGDFGM | TRDIYETDYY | RKGGKGLLPV | RWMSPESLKD |
1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
GVFTASSDMW | SFGVVLWEIT | SLAEQPYQGL | SNEQVLKFVM | DGGYLDPPDN | CPERLTDLMR |
1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
MCWQFNPKMR | PTFLEIVNLL | KDDLHPSFPE | VSFFYSEENK | APESEELEME | FEDMENVPLD |
1330 | 1340 | 1350 | 1360 | 1370 | |
RSSHCQREEA | GGREGGSSLS | IKRTYDEHIP | YTHMNGGKKN | GRVLTLPRSN | PS |